144 related articles for article (PubMed ID: 26412158)
1. The New Molecular Landscape of Cushing's Disease.
Sbiera S; Deutschbein T; Weigand I; Reincke M; Fassnacht M; Allolio B
Trends Endocrinol Metab; 2015 Oct; 26(10):573-583. PubMed ID: 26412158
[TBL] [Abstract][Full Text] [Related]
2. USP8: a novel therapeutic target for Cushing's disease.
Jian F; Cao Y; Bian L; Sun Q
Endocrine; 2015 Nov; 50(2):292-6. PubMed ID: 26162929
[TBL] [Abstract][Full Text] [Related]
3. Genetics of Cushing's disease: an update.
Perez-Rivas LG; Reincke M
J Endocrinol Invest; 2016 Jan; 39(1):29-35. PubMed ID: 26208471
[TBL] [Abstract][Full Text] [Related]
4. Decoding the genetic basis of Cushing's disease: USP8 in the spotlight.
Theodoropoulou M; Reincke M; Fassnacht M; Komada M
Eur J Endocrinol; 2015 Oct; 173(4):M73-83. PubMed ID: 26012588
[TBL] [Abstract][Full Text] [Related]
5. The Gene of the Ubiquitin-Specific Protease 8 Is Frequently Mutated in Adenomas Causing Cushing's Disease.
Perez-Rivas LG; Theodoropoulou M; Ferraù F; Nusser C; Kawaguchi K; Stratakis CA; Faucz FR; Wildemberg LE; Assié G; Beschorner R; Dimopoulou C; Buchfelder M; Popovic V; Berr CM; Tóth M; Ardisasmita AI; Honegger J; Bertherat J; Gadelha MR; Beuschlein F; Stalla G; Komada M; Korbonits M; Reincke M
J Clin Endocrinol Metab; 2015 Jul; 100(7):E997-1004. PubMed ID: 25942478
[TBL] [Abstract][Full Text] [Related]
6. Mutations in the deubiquitinase gene USP8 cause Cushing's disease.
Reincke M; Sbiera S; Hayakawa A; Theodoropoulou M; Osswald A; Beuschlein F; Meitinger T; Mizuno-Yamasaki E; Kawaguchi K; Saeki Y; Tanaka K; Wieland T; Graf E; Saeger W; Ronchi CL; Allolio B; Buchfelder M; Strom TM; Fassnacht M; Komada M
Nat Genet; 2015 Jan; 47(1):31-8. PubMed ID: 25485838
[TBL] [Abstract][Full Text] [Related]
7. The USP8 mutational status may predict drug susceptibility in corticotroph adenomas of Cushing's disease.
Hayashi K; Inoshita N; Kawaguchi K; Ibrahim Ardisasmita A; Suzuki H; Fukuhara N; Okada M; Nishioka H; Takeuchi Y; Komada M; Takeshita A; Yamada S
Eur J Endocrinol; 2016 Feb; 174(2):213-26. PubMed ID: 26578638
[TBL] [Abstract][Full Text] [Related]
8. Targeting the ERK pathway for the treatment of Cushing's disease.
Zhang D; Bergsneider M; Wang MB; Heaney AP
Oncotarget; 2016 Oct; 7(43):69149-69158. PubMed ID: 27708250
[TBL] [Abstract][Full Text] [Related]
9. Impact of USP8 Gene Mutations on Protein Deregulation in Cushing Disease.
Weigand I; Knobloch L; Flitsch J; Saeger W; Monoranu CM; Höfner K; Herterich S; Rotermund R; Ronchi CL; Buchfelder M; Glatzel M; Hagel C; Fassnacht M; Deutschbein T; Sbiera S
J Clin Endocrinol Metab; 2019 Jul; 104(7):2535-2546. PubMed ID: 30844069
[TBL] [Abstract][Full Text] [Related]
10. Recurrent gain-of-function USP8 mutations in Cushing's disease.
Ma ZY; Song ZJ; Chen JH; Wang YF; Li SQ; Zhou LF; Mao Y; Li YM; Hu RG; Zhang ZY; Ye HY; Shen M; Shou XF; Li ZQ; Peng H; Wang QZ; Zhou DZ; Qin XL; Ji J; Zheng J; Chen H; Wang Y; Geng DY; Tang WJ; Fu CW; Shi ZF; Zhang YC; Ye Z; He WQ; Zhang QL; Tang QS; Xie R; Shen JW; Wen ZJ; Zhou J; Wang T; Huang S; Qiu HJ; Qiao ND; Zhang Y; Pan L; Bao WM; Liu YC; Huang CX; Shi YY; Zhao Y
Cell Res; 2015 Mar; 25(3):306-17. PubMed ID: 25675982
[TBL] [Abstract][Full Text] [Related]
11. Clinical Spectrum of USP8 Pathogenic Variants in Cushing's Disease.
Rebollar-Vega RG; Zuarth-Vázquez JM; Hernández-Ramírez LC
Arch Med Res; 2023 Dec; 54(8):102899. PubMed ID: 37925320
[TBL] [Abstract][Full Text] [Related]
12. Nur77 gene expression levels were involved in different ACTH-secretion autonomy between Cushing's disease and subclinical Cushing's disease.
Tabuchi Y; Kitamura T; Fukuhara A; Mukai K; Onodera T; Miyata Y; Hamasaki T; Oshino S; Saitoh Y; Morii E; Otsuki M; Shimomura I
Endocr J; 2016 Jun; 63(6):545-54. PubMed ID: 27025408
[TBL] [Abstract][Full Text] [Related]
13. Cushing's disease: towards precision medicine.
Kaiser UB
Cell Res; 2015 Jun; 25(6):649-50. PubMed ID: 25930709
[TBL] [Abstract][Full Text] [Related]
14. Genetics of Cushing's disease: from the lab to clinical practice.
Theodoropoulou M; Reincke M
Pituitary; 2022 Oct; 25(5):689-692. PubMed ID: 35852754
[TBL] [Abstract][Full Text] [Related]
15. Genetics of Cushing's disease.
Albani A; Theodoropoulou M; Reincke M
Clin Endocrinol (Oxf); 2018 Jan; 88(1):3-12. PubMed ID: 28850717
[TBL] [Abstract][Full Text] [Related]
16. Expression of genes related to corticotropin production and glucocorticoid feedback in corticotroph adenomas of dogs with Cushing's disease.
Teshima T; Hara Y; Takekoshi S; Teramoto A; Osamura RY; Tagawa M
Domest Anim Endocrinol; 2009 Jan; 36(1):3-12. PubMed ID: 18818046
[TBL] [Abstract][Full Text] [Related]
17. USP8 Mutations and Cell Cycle Regulation in Corticotroph Adenomas.
Martins CS; Camargo RC; Coeli-Lacchini FB; Saggioro FP; Moreira AC; de Castro M
Horm Metab Res; 2020 Feb; 52(2):117-123. PubMed ID: 32053843
[TBL] [Abstract][Full Text] [Related]
18. Biophysical and structural insight into the USP8/14-3-3 interaction.
Centorrino F; Ballone A; Wolter M; Ottmann C
FEBS Lett; 2018 Apr; 592(7):1211-1220. PubMed ID: 29473952
[TBL] [Abstract][Full Text] [Related]
19. New Molecular Targets for Treatment of Cushing's Disease.
Foulkes E; Newell-Price J
Endocrinol Metab Clin North Am; 2018 Jun; 47(2):367-373. PubMed ID: 29754637
[TBL] [Abstract][Full Text] [Related]
20. Lack of Ubiquitin Specific Protease 8 (USP8) Mutations in Canine Corticotroph Pituitary Adenomas.
Sbiera S; Tryfonidou MA; Weigand I; Grinwis GC; Broeckx B; Herterich S; Allolio B; Deutschbein T; Fassnacht M; Meij BP
PLoS One; 2016; 11(12):e0169009. PubMed ID: 28005997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
